Currently most global healthcare resources are focused on coronavirus disease (COVID-19). This resource reallocation could disrupt the continuum of care for patients with chronic diseases. We aimed to evaluate the global impact of COVID-19 on routine care for chronic diseases.

We developed an English language nine-item online survey targeted at healthcare professionals (HCPs) across the globe, using a drop-down menu format. Prior to dissemination the survey was tested by a group of HCPs for the time to complete and to ensure no questions were distressing. The survey was administered between March 31 and April 23, 2020. The survey link was posted to social media (including Twitter, Facebook, and Instagram), websites, and mailing lists. The posts were sharable to facilitate snowball sampling. Informed consent was obtained. Descriptive analyses were performed.

202 HCPs from 47 countries responded; 47% from Europe, 20% Asia, 12% South America, 10% Africa, 9% North America, 2% Oceania. 75 (37%) were primary care physicians, 40 (20%) hospital physicians, 46 (23%) nurses, and 41 (20%) other HCPs ([Table 1](#tbl1){ref-type="table"} ). Only 14% reported continuing face-to-face care for all consultations, whilst the majority reported a change to either a proportion (35%) or all now being carried out by telephone (45%). HCPs who selected other (6%), highlighted use of telemedicine where online video consultations were being used through Zoom, Skype, WhatsApp, Facebook messenger. Some reported home visits, or cancellation of all outpatient appointments.Table 1Responses from healthcare professionals who completed the online survey between March 31 and April 23, 2020.Table 1Survey questionsNo. (%)**Healthcare profession (n = 202)** Primary care physician75 (37.1) Hospital physician40 (19.8) Nurse46 (22.8) Other41 (20.3)  **How are you continuing to provide routine chronic disease management care for your patients? (n = 202)** Face-to-face29 (14.4) Telephone90 (44.6) Both (face-to-face and telephone)70 (34.7) Other13 (6.4)  **How has the management of chronic disease care for your patients been since the outbreak of COVID-19? (n = 202)** Very poor9 (4.5) Poor39 (19.3) Fair96 (47.5) Good52 (25.7) Excellent6 (3.0)  **What effect do you think changes in healthcare services has had on your patients with chronic disease since the outbreak of COVID-19? (n = 200)** No effect5 (2.5) Mild effect61 (30.5) Moderate effect92 (46.0) Severe effect42 (21.0)  **How frequently have your patients been impacted by medication shortages since the start of COVID-19? (n = 201)** Never32 (15.9) Rarely37 (18.4) Sometimes96 (47.8) Often35 (17.4) Always1 (0.5)  **Has the mental health of your patients worsened since the outbreak of COVID-19? (n = 200)** Yes (most patients)41 (20.5) Yes (some patients)118 (59.0) No, it has stayed the same36 (18.0) No, it has improved5 (2.5)

Diabetes (38%) was the condition reported to be most impacted by the reduction in healthcare resources due to COVID-19, followed by chronic obstructive pulmonary disease (COPD, 9%), hypertension (8%), heart disease (7%), asthma (7%), cancer (6%) and depression (6%) ([Fig. 1](#fig1){ref-type="fig"} ). Additionally, the two most common co-occurring chronic diseases for which care was impacted by COVID-19 were diabetes and hypertension (30%), diabetes and COPD (13%), heart failure and COPD (8%) ([Fig. 1](#fig1){ref-type="fig"}).Fig. 1Chronic disease and comorbidities most impacted by COVID-19 due to the reduction in care, based on responses by healthcare professionals who completed the online survey between March 31 and April 23, 2020Fig. 1

Whilst the overall management of chronic disease care for patients was reported to be fair (48%) or good (26%), most HCPs (67%) rated moderate or severe effects on their patients due to changes in healthcare services since the outbreak. Moreover, 80% reported the mental health of their patients worsened during COVID-19 ([Table 1](#tbl1){ref-type="table"}).

Findings from this global survey showed HCPs have adapted to new ways of delivering care using telemedicine in order to reduce face-to-face contacts. Adapting new ways of virtual healthcare and digital technologies is imperative to allow HCPs to continue routine appointments. Further, the use of apps can support self-management of chronic conditions, i.e. continuous glucose monitoring enables support with diabetes. However, the majority of people with non-communicable diseases live in low-middle income countries, where these technologies may not be widely available or practical \[[@bib1]\]. Moreover, those with multiple chronic conditions may rely heavily on regular check-ups or hospital appointments to manage risk factors, are left trying to adapt to non-face-to-face interactions, or experiencing delay in treatment which may potentially have severe consequences.

Limitations of this survey include that it was only disseminated in English, as part of our networks we may have preferentially approached those working in diabetes. Also, difficulty in obtaining responses from HCPs when workloads may have already increased considerably. There will be heterogeneity between countries in that some countries are currently not as affected by the virus compared to others, and regulations of lockdown and social distancing differ by country, thus further research is required.

To avoid a rise in non-COVID-19-related morbidity and mortality, including increased depression and anxiety, it is important that patients with chronic diseases continue to receive care in spite of the pandemic \[[@bib2]\]. Our study found that this is currently being done through face-to-face consultation in clinics (away from COVID-19 patients) or through virtual communication.
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